Phosphodiesterase genes and antidepressant treatment response: A review

Karin Esposito, Gillian W. Reierson, Huai Rong Luo, Gui Sheng Wu, Julio Licinio, Ma Li Wong

Research output: Contribution to journalReview article

23 Citations (Scopus)

Abstract

Depression results in a tremendous burden to individuals suffering from the disorder and to the global health economy. Available pharmacologic treatments for depression target monoamine levels and monoamine receptors. However, delayed onset of effect, partial or inadequate treatment response, and side-effects are significant limitations of current therapies. The search for a better understanding of mechanisms of depression and for new treatment targets has turned attention to intracellular mediators. Phosphodiesterases (PDEs) are enzymes that break down the intracellular second messenger mononucleotides cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). Recent data from animal and human studies indicate that PDEs may play a role in depression and in related stress conditions. PDE genes have been linked directly to depression and to other genes associated with psychiatric disorders.

LanguageEnglish
Pages177-185
Number of pages9
JournalAnnals of Medicine
Volume41
Issue number3
DOIs
Publication statusPublished - 2009

Keywords

  • Depression
  • GAF
  • Genetics
  • PDE10
  • PDE11
  • PDE4
  • PDE5
  • Phosphodiesterase

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Esposito, K., Reierson, G. W., Luo, H. R., Wu, G. S., Licinio, J., & Wong, M. L. (2009). Phosphodiesterase genes and antidepressant treatment response: A review. Annals of Medicine, 41(3), 177-185. https://doi.org/10.1080/07853890802441169
Esposito, Karin ; Reierson, Gillian W. ; Luo, Huai Rong ; Wu, Gui Sheng ; Licinio, Julio ; Wong, Ma Li. / Phosphodiesterase genes and antidepressant treatment response : A review. In: Annals of Medicine. 2009 ; Vol. 41, No. 3. pp. 177-185.
@article{3b565ad2c83345648aa1854911a537d7,
title = "Phosphodiesterase genes and antidepressant treatment response: A review",
abstract = "Depression results in a tremendous burden to individuals suffering from the disorder and to the global health economy. Available pharmacologic treatments for depression target monoamine levels and monoamine receptors. However, delayed onset of effect, partial or inadequate treatment response, and side-effects are significant limitations of current therapies. The search for a better understanding of mechanisms of depression and for new treatment targets has turned attention to intracellular mediators. Phosphodiesterases (PDEs) are enzymes that break down the intracellular second messenger mononucleotides cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). Recent data from animal and human studies indicate that PDEs may play a role in depression and in related stress conditions. PDE genes have been linked directly to depression and to other genes associated with psychiatric disorders.",
keywords = "Depression, GAF, Genetics, PDE10, PDE11, PDE4, PDE5, Phosphodiesterase",
author = "Karin Esposito and Reierson, {Gillian W.} and Luo, {Huai Rong} and Wu, {Gui Sheng} and Julio Licinio and Wong, {Ma Li}",
year = "2009",
doi = "10.1080/07853890802441169",
language = "English",
volume = "41",
pages = "177--185",
journal = "Annals of Medicine",
issn = "0785-3890",
publisher = "Informa Healthcare",
number = "3",

}

Esposito, K, Reierson, GW, Luo, HR, Wu, GS, Licinio, J & Wong, ML 2009, 'Phosphodiesterase genes and antidepressant treatment response: A review', Annals of Medicine, vol. 41, no. 3, pp. 177-185. https://doi.org/10.1080/07853890802441169

Phosphodiesterase genes and antidepressant treatment response : A review. / Esposito, Karin; Reierson, Gillian W.; Luo, Huai Rong; Wu, Gui Sheng; Licinio, Julio; Wong, Ma Li.

In: Annals of Medicine, Vol. 41, No. 3, 2009, p. 177-185.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Phosphodiesterase genes and antidepressant treatment response

T2 - Annals of Medicine

AU - Esposito, Karin

AU - Reierson, Gillian W.

AU - Luo, Huai Rong

AU - Wu, Gui Sheng

AU - Licinio, Julio

AU - Wong, Ma Li

PY - 2009

Y1 - 2009

N2 - Depression results in a tremendous burden to individuals suffering from the disorder and to the global health economy. Available pharmacologic treatments for depression target monoamine levels and monoamine receptors. However, delayed onset of effect, partial or inadequate treatment response, and side-effects are significant limitations of current therapies. The search for a better understanding of mechanisms of depression and for new treatment targets has turned attention to intracellular mediators. Phosphodiesterases (PDEs) are enzymes that break down the intracellular second messenger mononucleotides cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). Recent data from animal and human studies indicate that PDEs may play a role in depression and in related stress conditions. PDE genes have been linked directly to depression and to other genes associated with psychiatric disorders.

AB - Depression results in a tremendous burden to individuals suffering from the disorder and to the global health economy. Available pharmacologic treatments for depression target monoamine levels and monoamine receptors. However, delayed onset of effect, partial or inadequate treatment response, and side-effects are significant limitations of current therapies. The search for a better understanding of mechanisms of depression and for new treatment targets has turned attention to intracellular mediators. Phosphodiesterases (PDEs) are enzymes that break down the intracellular second messenger mononucleotides cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). Recent data from animal and human studies indicate that PDEs may play a role in depression and in related stress conditions. PDE genes have been linked directly to depression and to other genes associated with psychiatric disorders.

KW - Depression

KW - GAF

KW - Genetics

KW - PDE10

KW - PDE11

KW - PDE4

KW - PDE5

KW - Phosphodiesterase

UR - http://www.scopus.com/inward/record.url?scp=67650376194&partnerID=8YFLogxK

U2 - 10.1080/07853890802441169

DO - 10.1080/07853890802441169

M3 - Review article

VL - 41

SP - 177

EP - 185

JO - Annals of Medicine

JF - Annals of Medicine

SN - 0785-3890

IS - 3

ER -